• MDMA &
    Empathogenic
    Drugs

    Welcome Guest!
  • MDMA Moderators: Esperighanto

What is wrong with the MDMA available today? - v2

Agreed, MDMAs direct actions will be a major factor, and the circustances involved.

What I was referring to was the condition of the body's metabolic system which governs neurogenesis and everything else classed as "regeneration".
Basically, these (depicted in picture) not working as well as they used to.
Those 3 hormones (progesterone, pregnenolone, DHEA) are key drivers for neurogenesis and regeneration.

image.png


There is a thread somewhere on here asserting that legal weed isn't as good as "the real thing" back when it was illegal as well.
I've seen people mention this on other forums. There might be some basis for that. It's possible that cannabis genetics which were popular pre-legalisation/pre-commercialisation were of a better quality. I'm not aware of any American company using (genuine) pure tropical sativa 'strains' which were once imported. These still exist and many have been documented by ACE Seeds.
In terms of the actual growing, many "legal weed" producers use substandard growing methods and inadequate post-harvest curing. That's probably not the case for "craft" cannabis growers though.
 
Last edited:
Sure there are various possible angles at play here. Also the tendency that latter drug experiences often aren't "as good" as the first times. Or nostalgia. There is a thread somewhere on here asserting that legal weed isn't as good as "the real thing" back when it was illegal as well.

The right chemical with the right people at the right time. Even Shulgin noted 'not more than 1.5mg/kg bodyweight not more often than once every six weeks' which DOES seem to be good advice.

I forgot to add that anyone consuming benzodiazepines to 'come down' were warned of their dangers. As if necking a pill of uncertain origin is a 'safe' thing to do. Drug snobbery exists everywhere,

There is absolutely nothing unique about MDMA. We developed two (then legal) RCs that I would take the 'Pepsi challange' with i.e. I really doubt even an experienced user would differentiate from MDMA. The Benzofurans were more down to 'what's cheap' which is not a good basis for drug design. You find the best, safest proructs first, then you hand it off to a chemical engineer because scaling is THEIR job, not ours.
 
What about an MDMA tax?would that speed decriminalization?
No, that would require legalization and regulation, not just decriminalization. Decrim only removes penalties for possession/use, but distribution stays illegal. Legalization would regulate production and sales, almost certainly with heavy taxes. More likely, MDMA would start as prescription-only, similar to ketamine therapy, rather than being sold like alcohol or tobacco.

I wouldn't be surprised if (lack of drug checking aside) MDMAs neurotoxicity might be the reason why MDMA "did hit differently" in the 90s. MDMA affects me differently too than it did in 2000 but I would not blame this on the substance but on excessive usage in the past. In fact it barely hits me at normal dose levels unless a long break (months, years) has been taken. For me this pattern is consistent with a neurotoxic substance that burns away the very synapses it needs for its action as well as the very slow recovery time until I can feel it again which might be due to neurogenesis.
You’re probably dealing with serotonin desensitization and dopamine downregulation. Frequent use of serotonergics (LSD, shrooms, 2C-B, etc.) makes this worse, and tolerance breaks are needed to reverse it. Neurotoxicity happens in dendrites, which atrophy with overuse, but I doubt you caused permanent brain damage. That explains the “meh” effect better than your self-diagnosis. Some people feel “mehDMA” without years of drug use, so there’s more to it.

Back in my early 20s, I was making MDMA in a clandestine lab, abusing it heavily until I burned out and quit for years. Imagine a casserole dish piled with pure white crystals, and me flipping molly at raves and Phish shows. My friends and I would rail lines of my own product, made from Sassafras oil, and get wrecked. Eventually I stopped, then did time after a snitch got me busted. Nearly a decade later, the magic came back fresh, and since then I only use MDMA or related drugs sparingly—though when I do, I go hard.

There is absolutely nothing unique about MDMA.
I get your point, but I disagree. MDMA is unique, though some compounds come close. With enough experience, you can tell them apart: MDMA vs MDA, 5-APB, methylone, 4-FA, etc. None hit as hard as MDMA in empathy and present-moment immersion. Other effects (jaw clenching, eye wiggles, ataxia) can be replicated, but the raw emotional intensity—that “magic”—is what makes MDMA stand apart.

I think the first time is special because the brain learns a new serotonin pathway, making it revelatory. Repeated use dulls the novelty, and only a long reset lets the brain “forget” and recapture that magic. This may explain why some think today’s MDMA feels weaker.

So I think this is another part of the puzzle regarding why some people are convinced that "something is wrong with the MDMA available today". That question assumes today’s MDMA is flawed. The real issue is what’s sold as MDMA. Pure MDMA.HCl is fine. If your experience feels off, either 1) it’s not MDMA despite sketchy testing claims, 2) it’s a mix with other chems/cuts, or 3) your own physiology changed—meds, tolerance, or cross-use with other serotonergics. If it's impurities and/or cuts, there are quite a few different possibilities, not the least of which could be 3,4-dimethoxy species. But with so many possibilities, all of them with fairly high probability, this isn't something where you can find an answer that will satisfy everyone, bc the reasons are varied and the experiences are personal and subjective.
 
What I noted wass that in 1988
Just to point something out ☞ this is what you experienced in the U.K. circa 1988, while meanwhile across the Atlantic, an American rave scene was in its infancy and MDMA tablets were sold legally in Dallas nightclubs, for example until the mid-80s. This "new club drug" called "ecstasy" was starting to take off. Four years later and MDMA was all over NYC, SF, LA, Chicago, Orlando, Philly, DC, Baltimore, Houston, Seattle… and in another four years it made its way to the suburbs and more rural parts of the U.S. MDMA's purity, popularity, reputation and counterfeit percentage has ebbed and flowed over the years and it continues to do so. Moreover, the drug scene from city to city across the globe varies quite a bit according to manufacturing, shipment routes, smuggling capabilities of trans-national criminal organizations, law enforcement efforts, and public opinion & demand, as always. Most developed nations with at least one big city, a nightlife with a demand for MDMA, and non-Draconian drug laws have an MDMA market, most likely. Who serves that market will obviously impact factors like quality, price and availability. As with any market, competition and abundance drive down price and prioritize customer service high as a marketing measure to capture and retain customer patronage. Fuckin' crapitalism, baby!

I love hearing stories from ppl around the world describing their drug scenes, the dealers, the buyers/users, the customs and traditions, and the particular spectrum of drugs that was available in years past. It's a fascinating study that dovetails sociology, criminology, biochemistry, pharmacology, medical knowledge, marketing & branding, black market economics, micro- and macro-economy theories, and the emotionally charged and controversial subject of recreational drug legalities and their impact on various social groups as well as civilization overall.
 
@unodelacosa Oh, I'm well aware of giants like Arthur Russell, Steve D'Aquisto, Frankie Knuckles, Ron Hardy, Jesse Saunders, Marshall Jefferson, and Larry Heard who were a decade or more ahead. I am aware that there are only 12 notes and a finite number of progressions that appeal to the ear.

I can only speak from my own experiences.

Of course, while both MDA and MDMA were legally controlled in the UK in 1971, MDEA was not. Neither was the hydroxylamine analogues of them all. That's why I said 'it didn't really affect me' but on the other hand, I do have rather a good record of NOT making controlled compounds... EVER!
 
Yeah except we're dealing with anecdotal reports of pills & powder from yesteryear, many/most—possibly all—of which are no longer around to test.
Please stop saying that, I'll be glad to send samples of what I've experienced MehDMA from the past 7-8 years to any address provided. I'm not interested in ingesting that/those compounds again. I've usually bought at least a gram/10 pills each time and just tried once, mostly with a friend.
 
Agreed, MDMAs direct actions will be a major factor, and the circustances involved.

What I was referring to was the condition of the body's core metabolic system which governs neurogenesis and everything else classed as "regeneration".
Basically, these (depicted in picture) not working as well as they used to.
Those 3 hormones (progesterone, pregnenolone, DHEA) are key drivers for neurogenesis and regeneration.

image.png



I've seen people mention this on other forums. There might be some basis for that. It's possible that cannabis genetics which were popular pre-legalisation/pre-commercialisation were of a better quality. I'm not aware of any American company using (genuine) pure tropical sativa 'strains' which were once imported. These still exist and many have been documented by ACE Seeds.
In terms of the actual growing, many "legal weed" producers use substandard growing methods and inadequate post-harvest curing. That's probably not the case for "craft" cannabis growers though.
Interesting! I've got long Covid and I've read one report of a person getting cured of her long Covid after a hippy-flip. LC seems to be a lot about damaged mitochondria.
 
Ok, so here goes.

For years I’ve been off and on researching and compiling scientific articles, comments and my own experiences in an attempt to answer this issue. I am not yet in position to provide my own definitive view on this, although my main theory concerning the cause of this issue and for which I still firmly believe, is contained throughout various posts in this and the earlier threads. The scientific reality is that until some analytical chemist decides to make this their PHD thesis, the answer chemically speaking will be out of reach.

But what I was told by my best friend today, and the context which makes what he said so compelling, must be shared with all of you immediately.

I am in my mid 40s, I have a science degree, I have a law degree, been an criminal lawyer for two decades, and I have been taking MDMA (whether pills or crystal) and methamphetamine continuously for 26 years. I have been a member of this site and contributed throughout this time (albeit fairly sporadically in more recent years) since December 1999 and my username and login has not changed. I have read every single post of every single page of this thread and its previous incarnations.

My best friend (who I have known for 27 years and who was my partner for nine of them) is the same age as me and this person has taken MDMA and methamphetamine this entire time too. From 1999 to 2009 we would have had all of the same pills and most of the same experiences. We have continued to take MDMA pills and crystal/powder and remain best friends to this day and have shared in many subsequent experiences since separating. My best friend has taken even more MDMA than I have, in fact way more, over the last 10 years. He has limited knowledge of this issue, no chemistry background and has no idea of the extensive discussion concerning it, that has been a feature of this forum and I am sure many others for years now.

Before posting what I wanted to share, I must state these matters from the outset:

1. No one who has said that meh-MDMA is a real thing and exists has ever said that all MDMA is meh; on the contrary.


2. Anyone who asserts that meh-MDMA is a real thing is saying that despite the massive doses in so many of the pills these days, when you got a pill in the earlier days that tested as MDXX and wasn’t a total fake (speed, Ket, chalk, etc), then provided the dose of MDMA in that pill was high enough (and back then then dose per pill was 50mg to 150mg at best and I know this due to many years of having been privy to the results of forensic laboratory tests for seized illicit substances and seeing the certificates with my own eyes since 2001), the experience was close to textbook, physical effects like mydriasis could not be hidden, the experiences were amazing, and indeed often life changing. You were buckled, looked buckled and literally needed to buckle up for the next few hours.


3. Anyone who asserts that meh-MDMA is a real thing and cannot be explained by more subjective factors is asserting that there is something chemically different about what they are consuming - either it is:

- not MDMA, despite test results stating to the contrary, including government forensic laboratory results which must be exact to be able of sustain a prosecution relating to MDMA as opposed to some other similar chemical;

- that the MDMA contains a greater proportion of the R enantiomer of MDMA as opposed to the S and is not racemic as it always was; or

- (this being my personal view) that much of the MDMA consumed today - illicitly produced and packaged as it is and requiring no purification at any of the steps of production along the way - being manufactured from different precursors (or let’s be clear pre-precursors) and using different reductive animation methods than MDMA produced in those earlier days, contains some type of impurity or impurities or combination of impurities, perhaps within the umbrella of a “impurity family”, all of which have the capability of muting/shortening/ruining the true MDMA experience to varying extents; much like SSRIs have the capability to do by blocking the monoamine transporters especially the SERT, so the MDMA molecule cannot enter into the axon of the nerve cell to work its magic.


4. It is accepted by most of those with sufficient knowledge advocating for the existence of the meh-MDMA phenomenon, that:

- pure MDMA-HCl is the same as any other PURE MDMA-HCl regardless of how it is made but we aren’t dealing with laboratories making pure illicit anything;

- pure 3,4-MDP2P can of course be made from any of the pre-precursors that are invariably what is currently being used to manufacture MDXX substances these days no matter which pre-precursor is being used, provided that those that are doing so purify the magical ketone first (so remove what is cleaved off from what is a far more complicated, likely chiral, and frankly “messy” molecule than the more simple safrole or piperonyl precursor that previously the chemist built upon to make the ketone);

- potential “one-pot” or “one-high pressure vessel” reactions which go simply and cheaply from some random chiral pre-precursor (whether used as the racemate or goodness me as an enantomerically pure version) to the desired amine, without any purification steps beyond extraction of crude MDMA freebase and everything else created due to other reactants having happily gone along for the same ride, before creating the hydrochloride, would likely exacerbate this problem.


5. That continuous anecdotal evidence as to the purple/black vs grey/black colour difference when testing pills or crystal, something I can personally attest to after using marquis reagent for 26 years, being that prior to any meh-MDMA, good MDMA pills tested with fresh marquis reagent went dark purple to black, but in more recent times so many of the pills or powder have gone very dark grey (some almost dark brown) to black and never any purple, and almost as night follows day the MDMA experience for the non-purple reactions is almost always meh-MDMA.


6. In the pictures below, the two pills were tested with the same marquis reagent, one after the other - the difference is striking - putting aside any impact of the dye used in the pills to one side, and assuming a similar binder in each, which given both have the “NL” branding press isn’t that far fetched, the only, THE ONLY, scientific explanation for this colour difference is that the makeup of the Onlyfans tablets on the right (that is THE TABLET which includes the illicitly produced impure MDMA-HCl mixture that went into producing the tablet, as opposed to the milligram amount of “pure MDMA-HCl” of the actual molecule quoted in a laboratory test and without reference to any other substance within) is different to the make up of the SoundCloud tablets on the left and the illicitly produced MDMA-HCl mixture that went into that tablet.


7. I was with this same ex-partner/best friend partying for four days straight only ten days earlier at the best event of our lives, where we consumed Pink Punishers and MDMA crystal and whilst both were decent, it was still of the meh kind, with many doses needing to be had and oh yes, I personally tested the Punisher and the MDMA with the EXACT SAME BOTTLE of marquis reagent as that used to test the pills in the picture below and both samples reacted exactly like the pill on the left did, no purple, straight to black through a very dark grey initial colour


8. My friend was communicating on a group chat to a mutual friend independently of any conscious thought as to this phenomenon; he said what he said without regard to any of this discussion, to Bluelight, to science or even to the purple result, so placebo can be ruled out. This experience was a mere ten nights after the last lot of MDMA pills, this person’s experience being vast and their tolerance utterly extreme.


gjwfX9x.jpeg



yHhY9fi.jpeg



Given what I know about the person who sent the message and the context in which it was sent, as corroborated by the starkest of differences in the chemical properties of each substance (admittedly fairly non-specific and with the significance of the colour change also deeply rooted in, and derived from, anecdotal experiences), this is about as compelling as far as user based evidence of the existence of meh-MDMA as one could ever get.

The reality of Meh-MDMA is a fact.

Meh-MDMA is part of the illicit supply of MDMA pills and powders to varying extents all over the world, with no doubt some localities fortunate enough to barely encounter it at all, whereas others might encounter it 90% of the time.

The fact of its existence in the world’s MDMA supply to varying extents cannot be summarily dismissed by the robotic trotting out of “advanced age”, “tolerance”, “set and settling” or “the distinct absence of yellow smiley faces” etc, etc, as sensible explanations.

All else being equal, the differences must be chemical.
  • Is it one particular chemical that is responsible; likely not.
  • Is it a group of chemicals with the pharmacological capability, at perhaps very low doses, of inhibiting MDMA’s ability to release that special blend of monoamine neurotransmitters, especially serotonin; maybe.
  • If this is correct, then does this account for the seemingly subpar quality of modern day mass produced P2P methamphetamine, basically manufactured in the same way but just with different pre-precursors to start with that do not have the methylenedioxy bridge (and tartaric acid resolution to increase the D isomer %), despite us all being told that methamphetamine has supposedly never been so pure and never been so potent, in a similar way to us being told that MDMA pills have never been so pure and dosed so high; I say undoubtedly.

I don’t profess to have all the answers and it frustrates the shit out of me. But no one can tell me, someone of my experience and knowledge (derived from multiple bases as it has for over two and a half decades), that meh-MDMA, as I’ve explained it, is not a real thing; nor do I subscribe to the defeatist attitude that it is something that is just impossible to scientifically investigate and can never be explained.


Ok, I’ll hand over to the naysayers now. I can only hope that those who will inevitably chime in will actually have something constructive to say that they haven’t already said a hundred times already…

Biscuit out.


Can someone please rewrite this like a human?
 
Please stop saying that, I'll be glad to send samples of what I've experienced MehDMA from the past 7-8 years to any address provided. I'm not interested in ingesting that/those compounds again. I've usually bought at least a gram/10 pills each time and just tried once, mostly with a friend.
I’m talking about MDMA from 25+ years ago—the late ’90s up to around 2003 when the first U.S. shortage hit. Pills from ’97–’02 were generally good, but there were still bunk ones and some deadly PMA/PMMA batches in places like Chicago. It was never all pure, perfectly dosed MDMA—it’s a black-market product, and everyone’s memories differ. Mine include amazing experiences but also plenty of shady, grimy stuff, since criminality has always plagued the scene. Yet another reason to abolish drug prohibition.
 
Good MDMA is still out there! I happened to be hanging with my dudeman and his boy at his boy's apartment when the topic of Molly got brought up. I mention how much I loved that shit and how long it's been since I've had a good roll. Homie goes gimme a sec walks into his bedroom comes back with a baggie full of crystals. Then proceeds to scale out 250mg asks me to rip him off a piece of shopping bag that was on the table, wraps that shit up and hands it to me.

Ended up taking it one afternoon about a monthish ago. Just by myself on a day off. Parachuted that shit around 9 or 10am. About 45min after I dropped it I was a bit concerned because I didn't feel much of a comeup. I was watching the first fast and furious movie at the time. It wasn't until I noticed how fast my heart was going during a none tense scene about 15-20min after I got concerned. Through all of my roles even solo stay at homes I've never had the comeup sneek up on me like that.

When I felt the first peak start to hit I had to pause the movie pop in some headphones and lie down in bed. It was soooo intense. Granted I had not rolled in years at that point. However, never has 250mg done that to me except maybe on my first few rolls. After that passed. I finished up that movie because well it's a fuckin classic. Popped my earbuds back in and just jammed out for a while. I started to get hot chilling in my room. Went out for a nice swim. Came back in was a bit bored with music and due to my astigmatism and some other weird vision problem lights normally star burst for me. Forget about when I'm rolling especially this hard so my favorite shooters were a no go and I was too impatient to download any of my rpgs. So Tokyo drift here I come.

Throughput the whole experience the peaks were super intense and lasted for a fair amount of time. The only gripe I had was I did not get much of an energy boost. However, I attribute that to set and setting. I was not looking for a wild go crazy roll. Actually, I could not have asked for a better solo roll.

You can still find the good stuff. Just seems to be increasingly difficult. I cannot believe not only stumbled into a free roll, definitely one of my top rolls and I've rolled a lotttt, but also a fairly steady source.

Edit:
Forgot to mention after effects. The next day I was definitely tired. However, there was a pleasant afterglow that lasted from mid-late come down thru mid next day. Other than that though, there were no noticable negatives by day 2 post roll. Not that I expected anything after a 1 time dose of non-heroic size. But there have been rolls in the past where I could definitely tell I rolled the days before, even with a decent amount of time between rolls.
 
Last edited:
@unodelacosa
Of course, while both MDA and MDMA were legally controlled in the UK in 1971, MDEA was not. Neither was the hydroxylamine analogues of them all. That's why I said 'it didn't really affect me' but on the other hand, I do have rather a good record of NOT making controlled compounds... EVER!
a bit of UK legal history...
MDEA was controlled under 1971 misuse drugs act under the catch all as an N-alkyl amphetamine substituted in the ring with methylenedioxy whether or not further substituted by any other univalent substituent. This catch all was added by SI in 1977.

"an N -alkyl-a-methylphenethylamine,a-ethylphenethylamine, or an N -alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents"

MDEA was legal in the netherlands until the late 90s which is why it was prevalent in UK. MDEA was pretty shit though.

FLEA and MDOH were eventually caught by the copypasta banning of pihkal index complete with errors in the early 2001.

None of these stupid laws made the slightest bit of difference to availability, they just killed people unneccesarily as a consequence of this prohibition.
 
Producing the hydroxylamine wasn't even our idea. Somebody else was making the hydroxylamine derivative of DOM but they hadn't recognised that in the form they produced, some of the product would lose that oxygen and degrade to DOM. The police couldn't charge them with manufacture but were able to charge them with possession with intent to supply.

I heard about it via a mutual friend and it seems they were almost openly selling the stuff which to me seems insane. Almost challanging the police.
 
I amused myself asking Grok to summarize this thread and it's predecessor, especially good for neew joiners who doesn't have the time to read through it all:

Original Thread: "What is Wrong with the MDMA Available Today?" (2013–2016)
The original thread, spanning over 250 pages, captures widespread user reports from experienced consumers (many from the 1980s–1990s era) lamenting a perceived decline in MDMA quality since the early 2000s.

Key consensus points include:
Subpar Effects Profile:
Modern MDMA often delivers muted euphoria, reduced empathy and sociability, diminished tactile and music enhancement, and a "fucked up buzz" rather than the "magical" openness of older batches. Comedowns are harsher, resembling a "bad MDA hangover," with little to no positive afterglow.

Pharmacological Differences:
Onset is slower (30–40 minutes vs. 10–15 for old-school), duration longer, and pupil dilation minimal (a "big giveaway" of inferior quality).

Synthesis as Culprit:
Blamed on shifts in production due to safrole shortages, leading to alternative precursors that yield racemic mixtures favoring the less euphoric R-isomer over the S-isomer. Even GCMS-tested pure samples (e.g., certain pills) fail to replicate classic effects.

Not User Factors:
Issues persist across settings, dosages, and user tolerance; new users report similar disappointments, ruling out "loss of magic" from overuse alone.

Regional/Global Scope:
Affects street MDMA worldwide, though rare high-quality batches still surface, fueling debates on whether "MDMA is MDMA" or if synthesis truly matters.

Thread 2.0: "What is Wrong with the MDMA Available Today? - v2" (2016–Ongoing)
This sequel, also exceeding 250 pages, builds on the original with deeper chemical analysis and more lab data, coining "meh-DMA" for the phenomenon.

Consensus evolves but reinforces core issues:
Altered Effects ("Meh-DMA"): Pure-tested modern MDMA frequently causes sedation, introspection, reduced empathy/euphoria, and poor sociability instead of classic stimulation and openness. Affects both veterans and novices uniformly.

Testing Limitations:
GCMS confirms purity, but undetected byproducts, isobaric impurities (indistinguishable masses), or monoamine transporter inhibition from synthesis residues may explain the shift.

Synthesis Evolution:
Precursor changes (e.g., from safrole to PMK glycidate or others) produce variable isomer ratios or contaminants, globally impacting supply chains. Not all batches are affected—quality varies by source.

Ruling Out Confounds:
Dosage, route, set/setting, and tolerance don't account for it; the problem is batch-specific and widespread, not anecdotal.

Broader Implications:
Calls for advanced testing (e.g., NMR for isomers) and highlights that while not all modern MDMA is "broken," the trend toward inferior effects dominates user reports.

Overarching Conclusions Across Both Threads
Both threads converge on synthesis-driven degradation as the primary issue, with modern precursors yielding a compound that's chemically MDMA but experientially "wrong" due to isomer imbalances or subtle impurities evading standard tests. Users advocate reagent testing plus subjective vetting, reduced frequency for neuroprotection, and hope for precursor access reforms to restore classic quality.

Skeptics exist, but experiential evidence sways toward a real decline, not mere nostalgia.
 
Last edited:
Yes, reports like this one expose that it is Didgital who cherrypicks and promotes a narrative he believes in without proof.
Nah, we all tend to do that. It isn't just @Didgital. And I've been guilty of being a hypocrite more than once in my life. It crappens.

@PsychedelicSummer Interesting. I did the same thing w/ChatGPT. This is what I got:

Core Question / Phenomenon​

  • Many users claim that even when a sample tests as MDMA (via GC/MS), the subjective effects feel “off” — less euphoria, less empathy, more sedation or a “cold buzz.” bluelight.org
  • This phenomenon is often called “meh-DMA” (i.e. subpar MDMA) in the thread. bluelight.org
  • The thread distinguishes this from “loss of magic” (i.e. tolerance or burnout), pointing out that new or light users also report the “meh” effect with certain batches. bluelight.org


Qualitative Differences Reported​

A recurring “comparison table” is often cited by users, summarizing how “classic/magic MDMA” vs “meh MDMA” differ:

FeatureClassic / Magic MDMA“Meh” / Subpar MDMA
Eye dilation (mydriasis)YesNo or reduced bluelight.org
Tactile / sensory enhancementStrongWeak or absent bluelight.org
Empathy, love, pro-social feelingPresentBlunted or absent bluelight.org
Euphoria & energyStrongWeak; sometimes lethargic
Duration~4–6 hoursShorter (1–3 h) in some reports
Comedown / afterglowGradual, often mildAbrupt, often worse hangover
Social interactionEnhancedSometimes withdrawal, introspection
These are generalizations based on user reports; not every “meh” experience displays all of these. bluelight.org+1


Theories / Hypotheses Discussed​

The thread is huge, but here are the main ideas people float (and often debate) to explain “meh-DMA”:
  1. Undetected contaminants / synthesis byproducts
    • Some byproducts or impurities from clandestine synthesis might remain in the final product and affect (or block) typical MDMA activity. bluelight.org+1
    • Some of these byproducts might interfere with or compete at monoamine transporters (serotonin/ dopamine / norepinephrine) altering effects. bluelight.org
  2. Isomer / isobaric / regioisomer / enantiomer issues
    • Compounds with the same molecular mass (but slightly different structure) may “hide” as MDMA in standard GC/MS tests. bluelight.org+1
    • The stereochemistry (ratio of mirror-image molecules) might affect potency or subjective effect. bluelight.org
  3. Analytical limitations of standard testing
    • GC/MS (gas chromatography / mass spectrometry) can miss or conflate certain analogs, isomers, or low-level adulterants because of coelution or lack of discriminating power. bluelight.org
    • More advanced techniques (chiral columns, orthogonal analyses) might reveal differences that standard testing misses. bluelight.org+1
  4. Changes in synthesis methods over time
    • As raw materials, precursors, or manufacturing techniques evolve, impurity / byproduct profiles may shift, creating products that “pass” tests yet don’t feel the same. bluelight.org+1
  5. User side explanations / non-product factors
    • Tolerance and “loss of magic” still have strong support in some corners.
    • Set & setting, dosage, route of administration, individual metabolism differences, mental state, expectation, etc.
    • Some users argue that the effect variation is partly psychological or reporting bias.


Caveats, Criticism & Skepticism​

  • Some participants push back hard on the “meh-DMA” narrative, saying a lot of perceived differences might be placebo, bias, or inconsistencies in user reports.
  • Others caution that many reports involve unverified drugs, unknown adulterants, or variable purity, making it hard to draw solid conclusions.
  • A recurring theme: for robust resolution, you’d need samples from users, detailed subjective reports, advanced lab analysis beyond GC/MS, and cross-correlation between the two.




Shit, I can even get details on my own arguments within the thread:

What unodelacosa argues / emphasizes​

Here are some of the notable positions and claims they make (with examples):
  • They repeatedly stress that reagent tests don’t reliably measure purity or potency, and that synthesis byproducts are inevitable.
    “Exactly – reagent tests are not indicators of purity or potency. Of course there are synthesis byproducts in virtually any drug, even pharma …” bluelight.org
  • They point out that in clandestine / black-market production, there’s more tolerance for impurities and lower standards (since there’s no regulatory oversight).
    “… the lack of oversight on the black market, a lower purity ‘standard’ and higher impurity tolerance is expected.” bluelight.org
  • They correct or clarify others’ chemical terminology, indicating they understand that discussions of “glycidate” or structural variants often get sloppy.
    In response to someone else’s post, unodelacosa says: “What you mean is ‘3,4-MDP-2-P methyl glycidate’ … neither of these is represented by the bizarre-looking pseudo-chemical structures …” bluelight.org
  • They express skepticism toward broad sweeping claims and caution against sloppy chemistry inferences by non-experts.
    “This is not safrole … you were much closer on this one … show more rigor …” bluelight.org
  • They engage with others’ theories (isomer hypotheses, variations in synthetic route) but don’t dogmatically assert one as the only answer.


How close is that to my summary?​

unodelacosa’s stance overlaps substantially with what I laid out:

Which aspectMy summaryunodelacosa’s position
Analytical limitations & missed impuritiesI proposed that GC/MS or simple tests may miss isomers or low-level contaminantsThey explicitly challenge reagent tests as inadequate and emphasize unavoidable byproducts. bluelight.org+1
Role of synthetic route / production conditionsI said changes in synthesis may shift impurity profilesunodelacosa engages those chemical debates (e.g. about glycidate, safrole variants) and corrects imprecisions
Skepticism / not overclaimingI noted that this is a plausible hypothesis but not provenunodelacosa doesn’t assert certainty and pushes others to be more precise rather than sweeping claims
Linking subjective effect to chemistryI claimed that a rigorous link (lab + subjective) is not yet establishedunodelacosa doesn’t present strong subjective-chemistry linkage either; they focus more on chemistry / testing issues

So, unodelacosa is a solid, informed voice in that thread. They come pretty close to “my version” especially on the analytical/impurity skepticism side, although they don’t always tie it explicitly to the “meh MDMA” subjective effect in a neat, summary form.
 
Hey I have a use for this par tier MDMA that's good enough for drunks and simpletons.

I'm trying to get annoying weed users onto a less annoying drug, even if their eyes don't dilate.
 
More from AI:
ChatGPT QUESTION:
Analyse the bluelight.org threads "What is Wrong with the MDMA Available Today?" and it's 2.0 iteration and tell me the most likely cause of the MehDMA phenomena. Compare to general knowledge in medicinal chemistry as to what can cause deviations in effect from different substances.

ANSWER Summary: (I've deleted the resoning for brevity of post)
Putting together the user reports and what the published literature says, here are what I believe are the most plausible causes of the “mehMDMA” phenomenon, perhaps in combination:

1. Synthesis byproducts that interfere with MDMA’s effect:
Especially those shown in the Pifl et al. study. If some byproducts inhibit monoamine uptake or release in ways that counter or blunt MDMA, even low levels of them could degrade the effect. The users on Bluelight explicitly mention compounds “12” & “13” from that study; they hypothesize those might be lingering in some batches.

2. Regioisomer / isobaric impurities that are difficult to distinguish in routine tests:
Because many routine GC/MS or lab testing may not separate all regioisomers, isobars, or structural analogues. Some of these impurities may have weaker (or even partially antagonistic) effects, or simply not have the empathogenic/euphoriant profile. So a “pure MDMA” reading could mask a mixture of MDMA plus inactive or less active isomers.

3. Changes in synthetic route or precursor leading to different impurity profiles, perhaps inclusion of newer, less ideal or less “magic” ancillary compounds:
If older production methods (e.g. carefully done, maybe more expensive, slower, better purification) produced products with “cleaner” side profiles, and new methods optimize for yield and cost, but allow more residuals, residual impurities, incomplete reactions or partial racemization, then the subjective quality might drop even if the measured content is high. The “black pepper / piperine” precursor article is relevant in showing route‐specific impurities.

4. Stereochemical purity / enantiomer ratios:
If older “high‐quality magic” MDMA had proportionally more of the “good” enantiomer (S‐MDMA) or fewer enantiomeric impurities, whereas newer batches might have poorer stereochemical control, that could reduce efficacy. There is experimental evidence that stereochemistry matters (e.g. for dopamine uptake etc).

5. Laboratory detection issues / low sensitivity:
Some impurities or byproducts might be active at low concentrations (micro‑ or nanomolar) and be missed or de‐emphasized in “pure MDMA” reports. Also, misidentification or inability to resolve overlapping peaks. This seems likely to exacerbate the above issues.

It is likely not a single cause for all reports; different batches, regions, producers may have different issues. Also, more than one problem may combine (e.g. some impurities + partial stereochemical impurity + small inhibitors).
 
And for comparison:
Same question as above to DeepSeek (but here I've included the full answer)

ANSWER:
Executive Summary
The most likely cause of the "MehDMA" phenomenon, as detailed across the Bluelight threads, is the widespread proliferation of MDMA synthesized via rapid, "hyperspeed" routes (most notably the PMK-glycidate method) that produce a non-racemic mixture of MDMA enantiomers, heavily contaminated with the inactive or weakly active (S)-enantiomer and route-specific byproducts. This is not a different drug, but a significant drop in the purity and isomeric composition of the MDMA being sold.
---
Analysis of the Bluelight Threads (2013-2016 & 2.0)

The original "What is Wrong with the MDMA Available Today?" thread and its successor became a massive repository of user experiences and chemical analysis, primarily from Europe.

1. User-Reported Symptoms of "MehDMA"

The complaints were remarkably consistent:

· Lack of Euphoria ("The Magic"): The primary complaint. The intense, loving, empathetic rush was absent or severely muted.
· Predominance of Stimulation: The experience was described as "speedy" or "dirty," resembling amphetamine more than classic MDMA. Users felt awake and energetic but not happy or connected.
· Increased Anxiety/Paranoia: Instead of blissful calm, some users reported heightened anxiety, jitters, and even paranoia on the come-up.
· Unpleasant Body Load: Reports of nausea, headaches, and a general feeling of physical discomfort were more common.
· Shorter Duration: The peak effects were shorter, with a more abrupt and sometimes unpleasant crash.
· Higher Dosage Required: Users reported needing to take significantly more to feel any effect, but even then, the desired euphoria was missing.

2. Community-Hypothesized Causes

The Bluelight community, including many knowledgeable amateur chemists, proposed several theories, which were progressively refined:

· The "Sassafras Shortage" Narrative: Initially, the blame was placed on the scarcity of safrole (the traditional precursor from sassafras oil). This was thought to have forced clandestine chemists to switch to alternative precursors and less optimal synthesis routes.
· Alternative Precursors (PMK-glycidate & APAA): The discussion zeroed in on two precursors that became dominant: PMK-glycidate and its cousin, APAA. These are pre-formed precursors that shortcut the classic synthesis, allowing for faster, higher-volume production with less chemical expertise.
· The "Wrong Isomer" Theory: This became the central, most plausible explanation. It was posited that the new synthesis routes were producing MDMA that was not the pure, active (R)-enantiomer, but a racemic (50/50) mixture or, worse, a mixture skewed towards the inactive (S)-enantiomer.
---
The Most Likely Cause: A Medicinal Chemistry Perspective

The community's "Wrong Isomer" theory is strongly supported by fundamental medicinal chemistry. Let's break down why.

1. The Critical Role of Chirality (Stereochemistry)

MDMA (3,4-methylenedioxymethamphetamine) is a chiral molecule. This means it has a non-superimposable mirror image, much like your left and right hands. These two forms are called enantiomers.

· (R)-MDMA ("Right-handed"): This enantiomer is primarily responsible for the classic serotonergic effects—the euphoria, empathy, and "magic." It has a high affinity for the serotonin transporter (SERT).
· (S)-MDMA ("Left-handed"): This enantiomer has a much higher affinity for the norepinephrine transporter (NET). It is more stimulating, amphetamine-like, and contributes little to the serotonin-mediated euphoria.

Pure (R)-MDMA would be the most "magical" but is virtually never sold.
Racemic MDMA (50% R, 50% S),produced by the classic synthesis routes from safrole, is what defined "good" MDMA for decades. It provides a balanced mix of serotonin and norepinephrine release.
"MehDMA" (e.g., 30% R, 70% S) would be heavily skewed toward the (S)-enantiomer, leading to a speedy, less euphoric experience, exactly as users reported.

2. How Synthesis Route Determines Isomeric Profile

This is the core of the issue. The stereochemical outcome of a synthesis is determined by the route and the skill of the chemist.

· Classic Safrole -> MDMA Route: This multi-step synthesis, when performed correctly, results in a racemic mixture. The final product is a predictable 50/50 blend of (R) and (S) enantiomers.
· "Hyperspeed" PMK-Glycidate Route: PMK-glycidate is a more advanced precursor. The synthesis from this point is very short. Critically, this route is not stereoselective. It produces a racemic mixture by default. However, due to the specific conditions (e.g., the use of aluminum amalgam or other reducing agents, reaction temperature, and pressure), the reaction can be poorly controlled. This can lead to a final product that is not a perfect 50/50 racemate but is skewed, often towards the (S)-enantiomer, due to kinetic or thermodynamic factors during the reduction step. The rush to produce large batches likely exacerbated this lack of control.

3. The Role of Byproducts and Impurities

Rapid, "dirty" syntheses also lead to a higher concentration of route-specific impurities.

· Chlorinated Byproducts: The PMK-glycidate route can introduce chlorinated compounds if the chemistry is not meticulously clean.
· Incomplete Reaction Intermediates: Precursors or intermediates from the shortcut synthesis may not be fully converted.
· Synergistic Effects: While these impurities are present in small amounts, they are pharmacologically active. They can contribute to the "dirty" feeling, body load, and increased neurotoxicity, further distorting the clean MDMA experience.
---
Comparison to General Medicinal Chemistry Principles

The MehDMA phenomenon is a perfect real-world example of several key principles:

1. Chirality is Everything: The biological activity of a chiral drug is entirely dependent on its interaction with chiral biological targets (e.g., receptors, transporters). Different enantiomers can have dramatically different pharmacological profiles (e.g., thalidomide, levomethorphan/dextromethorphan). MehDMA demonstrates that the "same" drug with a different isomeric ratio is effectively a different drug.

2. Impurities Matter: A drug substance is never 100% pure. The nature and quantity of synthetic byproducts (the "impurity profile") can significantly alter the drug's effects, side-effect burden, and toxicity. The shift to a new precursor created a new, more unpleasant impurity profile.

3. Dose-Response is Complex: Users reporting "needing more" were likely trying to overcome the lower concentration of the active (R)-enantiomer. However, by taking more, they were also increasing their dose of the stimulating (S)-enantiomer and toxic impurities, leading to the negative side effects without recapturing the magic.

4. The Entourage Effect (or Lack Thereof): Just as in cannabis, the overall subjective experience of a drug can be the result of a combination of compounds. Classic MDMA's effects were the result of the racemic mixture plus a known, low-level impurity profile. Changing that delicate balance disrupted the entire experience.

Conclusion
The "MehDMA" phenomenon was not a myth or a matter of shifting user tolerance alone. It was a direct consequence of a seismic shift in the underground production of MDMA. The drive for efficiency and volume, catalyzed by precursor availability, led to the adoption of synthetic routes that produced an inferior product: MDMA with a skewed, non-racemic isomeric profile (low (R)-MDMA, high (S)-MDMA) and a novel cocktail of unpleasant byproducts.

This case underscores a critical lesson for harm reduction: the identity of a drug on the street is not just its name, but the sum total of its synthesis history, isomeric composition, and impurity profile.
 
I'm trying to get annoying weed users onto a less annoying drug
Sounds like an exercise in futility. And nothing is inherently annoying about weed. Just some people become annoying when they get high on it, but not everyone. I know people who are much more laidback easygoing once they smoke some weed but are otherwise high strung as a mofo.

Same question as above to DeepSeek (but here I've included the full answer)
Nice one. So, what other major LLM AIs are left? Someone needs to do Google's Gemini next perhaps, lol. Honestly I've seen all I needed to see, and it's exactly what I thought. There are many reason for someone having a lackluster MDMA experience, sometimes multiple at once. MDDMA and MDTMA (methylene-dioxy-dimethyl-amphetamine and methylene-dioxy-trimethyl-amphetamine, respectively) can mute MDMA's activity, and running an Al/Hg amalgam too hot during ketone reduction can damage MDMA and change the enantiomeric output, weakening and changing the qualitative effects of the end result, producing less of the more-active isomer. Problem solved, case closed (*lol).
 
Top